Telix Pharmaceuticals Limited
About Telix Pharmaceuticals Limited
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: IPO T: - FT: IPO |
A: 200000000 MR: - FA: 200 million FAN: 200000000 |
D: 2024-06-05 FD: 2024-06-05 |
4 investors |
Growth Metrics
Team & Leadership
Tiffany Olson
Non-Executive Director and Chair
Christian Behrenbruch
Managing Director & Group Chief Executive Officer
Marie McDonald
Independent Non-Executive Director
Mark Nelson
Independent Non-Executive Director
Jann Skinner
Independent Non-Executive Director
Genevieve Ryan
Company Secretary
Recent News
Telix Pharmaceuticals Limited Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- telixpharma.com
- Industries
- Biopharmaceuticals
- Company Size
- ~460 employees (est.)
- Locations
-
Melbourne, Australia and Indianapolis, US
Melbourne, Australia and Indianapolis, United States
Melbourne, Australia +3 more
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro